Khan R, Khachemoune A
Indian Dermatol Online J. 2024; 15(4):584-592.
PMID: 39050063
PMC: 11265734.
DOI: 10.4103/idoj.idoj_756_23.
Chen X, Zhou L, Xia Y, Wong Y, He Q, Tang P
Eur Radiol. 2024; 34(10):6376-6383.
PMID: 38652159
PMC: 11399200.
DOI: 10.1007/s00330-024-10738-z.
Khorasanizadeh F, Kalantari Y, Etesami I
Skin Res Technol. 2023; 29(7):e13410.
PMID: 37522502
PMC: 10318382.
DOI: 10.1111/srt.13410.
Zhang F, Li J, Zhao Q, Liu H, Zhang F
Skin Res Technol. 2023; 29(3):e13300.
PMID: 36973989
PMC: 10155795.
DOI: 10.1111/srt.13300.
Tognetti L, Marrocco C, Carraro A, Guerrini G, Mariotti G, Cinotti E
Photodermatol Photoimmunol Photomed. 2022; 38(6):531-540.
PMID: 35324032
PMC: 9790552.
DOI: 10.1111/phpp.12786.
The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis.
Ruaro B, Santiago T, Hughes M, Lepri G, Poillucci G, Baratella E
Open Access Rheumatol. 2021; 13:79-91.
PMID: 33953621
PMC: 8092351.
DOI: 10.2147/OARRR.S282612.
Morphea: progress to date and the road ahead.
Abbas L, Joseph A, Kunzler E, Jacobe H
Ann Transl Med. 2021; 9(5):437.
PMID: 33842658
PMC: 8033330.
DOI: 10.21037/atm-20-6222.
Overview of Ultrasound Imaging Applications in Dermatology.
Almuhanna N, Wortsman X, Wohlmuth-Wieser I, Kinoshita-Ise M, Alhusayen R
J Cutan Med Surg. 2021; 25(5):521-529.
PMID: 33682489
PMC: 8474315.
DOI: 10.1177/1203475421999326.
Overview of Juvenile localized scleroderma and its management.
Li S, Zheng R
World J Pediatr. 2019; 16(1):5-18.
PMID: 31786801
DOI: 10.1007/s12519-019-00320-9.
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.
Agazzi A, Fadanelli G, Vittadello F, Zulian F, Martini G
Pediatr Rheumatol Online J. 2018; 16(1):37.
PMID: 29914516
PMC: 6006585.
DOI: 10.1186/s12969-018-0254-9.
A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: Does skin echogenicity matter?.
Liu H, Hou Y, Zhu Q, Xu D, Wang L, Li J
PLoS One. 2017; 12(3):e0174481.
PMID: 28339492
PMC: 5365121.
DOI: 10.1371/journal.pone.0174481.
Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.
Walker D, Susa J, Currimbhoy S, Jacobe H
J Am Acad Dermatol. 2017; 76(6):1124-1130.
PMID: 28285783
PMC: 5438266.
DOI: 10.1016/j.jaad.2016.12.020.
Preliminary Results on the Feasibility of Using ARFI/SWEI to Assess Cutaneous Sclerotic Diseases.
Lee S, Cardones A, Doherty J, Nightingale K, Palmeri M
Ultrasound Med Biol. 2015; 41(11):2806-19.
PMID: 26259888
PMC: 4593719.
DOI: 10.1016/j.ultrasmedbio.2015.06.007.
Correlates of self-reported quality of life in adults and children with morphea.
Das S, Bernstein I, Jacobe H
J Am Acad Dermatol. 2014; 70(5):904-10.
PMID: 24534655
PMC: 3992170.
DOI: 10.1016/j.jaad.2013.11.037.
Updates on morphea: role of vascular injury and advances in treatment.
Sartori-Valinotti J, Tollefson M, Reed A
Autoimmune Dis. 2013; 2013:467808.
PMID: 24319593
PMC: 3844232.
DOI: 10.1155/2013/467808.
Recent developments in diagnosis and assessment of morphea.
Nouri S, Jacobe H
Curr Rheumatol Rep. 2013; 15(2):308.
PMID: 23307579
DOI: 10.1007/s11926-012-0308-9.
